• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Turning Point Brands Announces Third Quarter 2023 Results and Closing of New ABL Facility

    11/8/23 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary
    Get the next $TPB alert in real time by email

    -Revised Annual Adjusted EBITDA Guidance to $92 to $95 million from $90 to $95 million

    -Repurchased Another $15 million of Outstanding Convertible Bonds

    Turning Point Brands, Inc. ("TPB" or "the Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today financial results for the third quarter ended September 30, 2023.

    Q3 2023 vs. Q3 2022

    • Total consolidated net sales decreased 5.6% to $101.7 million
      • Zig-Zag Products net sales decreased by 10.2% but stable sequentially
      • Stoker's Products net sales increased by 10.1%
      • Creative Distribution Solutions net sales decreased by 18.7%
    • Gross profit decreased 2.1% to $51.6 million
    • Net income decreased 6.1% to $10.8 million
    • Adjusted net income increased 1.6% to $14.5 million (see Schedule B for a reconciliation to net income)
    • Adjusted EBITDA decreased 0.4% to $24.4 million (see Schedule A for a reconciliation to net income)
    • Diluted EPS of $0.58 and Adjusted Diluted EPS of $0.76 compared to $0.60 and $0.72 in the same period one year ago, respectively (see Schedule B for a reconciliation to Diluted EPS)

    Graham Purdy, President and CEO, commented: "Our third quarter results were consistent with our expectations. The Zig-Zag segment was stable sequentially from the second quarter and notwithstanding some transitory headwinds posted its third-highest revenue quarter. Stoker's had another solid quarter of performance led by double-digit growth year-over-year in Stoker's MST. We further de-levered the balance sheet with an opportunistic purchase of $15 million in aggregate principal amount of our convertible notes during the third quarter. With a new $75 million ABL revolving credit facility, our strong cash balance, and our free cash flow generation, we now have more than ample liquidity to address the remaining balance of convertible notes maturing next year."

    Zig-Zag Products Segment (46% of total net sales in the quarter)

    For the third quarter, Zig-Zag Products net sales were consistent with the previous quarter but decreased 10.2% to $46.8 million as the previous year's third quarter benefitted from the initial load-in of CLIPPER lighters and approximately $5 million of sales from promotional activities and timing of Canadian deliveries. Additionally, a discontinuation of an unprofitable product line impacted Canadian sales by $1.8 million.

    For the quarter, the Zig-Zag Products segment gross profit decreased 4.6% to $26.7 million. Gross margin increased 330 basis points to 57.2% driven primarily by product mix.

    "Our alternative channel business had another quarter of strong double-digit growth as we continue to expand penetration in the growing market," said Purdy. "We remain encouraged by our prospects with secular cannabis consumption growth trends driving demand for our products."

    Stoker's Products Segment (36% of total net sales in the quarter)

    For the third quarter, Stoker's Products net sales increased 10.1% to $36.9 million on double-digit growth of MST and low-single-digit growth of loose-leaf chewing tobacco. For the third quarter, total Stoker's Products segment volume increased 2.2%, while price / mix increased 7.9%.

    For the quarter, the Stoker's Products segment gross profit increased 12.5% to $20.6 million. Gross margin expanded 120 basis points to 55.7% due to MST pricing gains.

    "Stoker's strong market share gains in both the MST and loose-leaf chewing tobacco categories continued as its value proposition continues to resonate with consumers," continued Purdy.

    Recent Events

    ABL Facility

    On November 7, 2023, a subsidiary of the Company closed on a new asset-based revolving credit facility with committed borrowing capacity of $75 million. The new facility replaces a $25 million senior secured revolving credit facility which was scheduled to mature in August 2025. The new facility is scheduled to mature in November 2027. The Company currently has no borrowings outstanding under the new facility.

    Performance Measures in the Third Quarter

    Third quarter consolidated selling, general and administrative ("SG&A") expenses were $31.4 million compared to $32.9 million in the third quarter of 2022.

    The third quarter SG&A included the following notable items:

    • $1.8 million of stock options, restricted stock and incentive expense compared to $1.4 million in the year-ago period
    • $0.3 million of FDA PMTA-related expenses for modern oral products compared to $1.2 million in the year-ago period
    • $0.2 million of restructuring costs related to CDS as compared to $0.0 million in the year-ago period
    • $0.1 million of transaction expenses compared to $0.0 million in the year-ago period
    • $0.1 million of ERP / CRM duplicative system costs compared to $0.4 million of ERP / CRM scoping expenses in the previous year

    Total gross debt as of September 30, 2023 was $368.5 million. Net debt (total gross debt less unrestricted cash) at September 30, 2023 was $272.5 million. The Company ended the quarter with total liquidity of $119.7 million, comprised of $96.1 million in cash and $23.6 million of revolving credit facility capacity.

    During the quarter, the Company repurchased $15.0 million in aggregate principal amount of its 2.50% Convertible Senior Notes due July 2024.

    The Company recorded an impairment charge of $2.2 million during the quarter related to historical minority investments in development stage ventures.

    2023 Outlook

    At this time, the Company expects full-year 2023 adjusted EBITDA to be $92 to $95 million (compared to previous outlook of $90 to $95 million).

    Creative Distribution Solutions ("CDS") (18% of total net sales in the quarter)

    The CDS business was restructured during the quarter to eliminate certain unprofitable businesses and focus on a narrower set of products to better position it as a standalone business.

    For the third quarter, CDS net sales were $18.1 million, gross profit was $4.3 million, and gross margin was 23.8%.

    Earnings Conference Call

    As previously disclosed, a conference call with the investment community to review TPB's financial results has been scheduled for 10:00 a.m. Eastern on Wednesday, November 8, 2023. Investment community participants should dial in 10 minutes ahead of time using the toll-free number 888-330-2502 (international participants should call 240-789-2713), and follow the audio prompts after typing in the event ID: 6640134. A live listen-only webcast of the call will be available on the Events and Presentations section of the investor relations portion of the Company website (www.turningpointbrands.com). A replay of the webcast will be available on the site two hours following the call.

    Non-GAAP Financial Measures

    In addition to financial measures prepared in accordance with generally accepted accounting principles in the United States (GAAP), this press release includes certain non-GAAP financial measures including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS and Adjusted Operating Income (Loss). A reconciliation of these non-GAAP financial measures accompanies this release.

    About Turning Point Brands, Inc.

    Turning Point Brands (NYSE:TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic Zig-Zag® and Stoker's® brands. TPB's products are available in more than 215,000 retail outlets in North America, and on sites such as www.zigzag.com. For the latest news and information about TPB and its brands, please visit www.turningpointbrands.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by TPB in this press release, its reports filed with the Securities and Exchange Commission (the "SEC") and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict or identify all such events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to those included it the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by the Company with the SEC. These statements constitute the Company's cautionary statements under the Private Securities Litigation Reform Act of 1995.

    Financial Statements Follow:

    Turning Point Brands, Inc.
    Consolidated Statements of Income
    (dollars in thousands except share and per share data)
    (unaudited)
     
    Three Months Ended September 30,

    2023

    2022

     
    Net sales

    $

    101,722

     

    $

    107,802

     

    Cost of sales

     

    50,100

     

     

    55,090

     

    Gross profit

     

    51,622

     

     

    52,712

     

    Selling, general, and administrative expenses

     

    31,385

     

     

    32,891

     

    Operating income

     

    20,237

     

     

    19,821

     

    Interest expense, net

     

    3,984

     

     

    4,802

     

    Investment loss (gain)

     

    2,101

     

     

    (75

    )

    Gain on extinguishment of debt

     

    (481

    )

     

    -

     

    Income before income taxes

     

    14,633

     

     

    15,094

     

    Income tax expense

     

    3,767

     

     

    3,797

     

    Consolidated net income

     

    10,866

     

     

    11,297

     

    Net gain (loss) attributable to non-controlling interest

     

    35

     

     

    (239

    )

    Net income attributable to Turning Point Brands, Inc.

    $

    10,831

     

    $

    11,536

     

     
    Basic income per common share:
    Net income attributable to Turning Point Brands, Inc.

    $

    0.62

     

    $

    0.65

     

    Diluted income per common share:
    Net income attributable to Turning Point Brands, Inc.

    $

    0.58

     

    $

    0.60

     

    Weighted average common shares outstanding:
    Basic

     

    17,595,980

     

     

    17,749,294

     

    Diluted

     

    20,098,450

     

     

    21,102,006

     

     
    Supplemental disclosures of statements of income information:
    Excise tax expense

    $

    5,288

     

    $

    5,747

     

    FDA fees

    $

    142

     

    $

    170

     

    Turning Point Brands, Inc.
    Consolidated Balance Sheets
    (dollars in thousands except share data)
     
    (unaudited)
    September 30, December 31,
    ASSETS

    2023

    2022

    Current assets:
    Cash

    $

    96,071

     

    $

    106,403

     

    Accounts receivable, net of allowances of $59 in 2023 and $114 in 2022

     

    10,493

     

     

    8,377

     

    Inventories

     

    116,926

     

     

    119,915

     

    Other current assets

     

    23,322

     

     

    22,959

     

    Total current assets

     

    246,812

     

     

    257,654

     

    Property, plant, and equipment, net

     

    24,613

     

     

    22,788

     

    Deferred income taxes

     

    8,190

     

     

    8,443

     

    Right of use assets

     

    12,060

     

     

    12,465

     

    Deferred financing costs, net

     

    203

     

     

    282

     

    Goodwill

     

    136,280

     

     

    136,253

     

    Other intangible assets, net

     

    81,725

     

     

    83,592

     

    Master Settlement Agreement (MSA) escrow deposits

     

    27,534

     

     

    27,980

     

    Other assets

     

    16,526

     

     

    22,649

     

    Total assets

    $

    553,943

     

    $

    572,106

     

     
    LIABILITIES AND STOCKHOLDERS' EQUITY
    Current liabilities:
    Accounts payable

    $

    11,237

     

    $

    8,355

     

    Accrued liabilities

     

    27,227

     

     

    33,001

     

    Current portion of long-term debt

     

    48,248

     

     

    -

     

    Other current liabilities

     

    6

     

     

    20

     

    Total current liabilities

     

    86,718

     

     

    41,376

     

    Notes payable and long-term debt

     

    316,573

     

     

    406,757

     

    Lease liabilities

     

    10,433

     

     

    10,593

     

    Total liabilities

     

    413,724

     

     

    458,726

     

     
    Commitments and contingencies
     
    Stockholders' equity:
    Preferred stock; $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-

     

    -

     

     

    -

     

    Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 19,912,882 issued shares
    and 17,596,422 outstanding shares at September 30, 2023, and 19,801,623 issued shares and
    17,485,163 outstanding shares at December 31, 2022

     

    199

     

     

    198

     

    Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000;
    issued and outstanding shares -0-

     

    -

     

     

    -

     

    Additional paid-in capital

     

    117,143

     

     

    113,242

     

    Cost of repurchased common stock
    (2,316,460 shares at September 30, 2023 and December 31, 2022)

     

    (78,093

    )

     

    (78,093

    )

    Accumulated other comprehensive loss

     

    (3,855

    )

     

    (2,393

    )

    Accumulated earnings

     

    103,517

     

     

    78,691

     

    Non-controlling interest

     

    1,308

     

     

    1,735

     

    Total stockholders' equity

     

    140,219

     

     

    113,380

     

    Total liabilities and stockholders' equity

    $

    553,943

     

    $

    572,106

     

    Turning Point Brands, Inc.
    Consolidated Statements of Cash Flows
    (dollars in thousands)
    (unaudited)
     

    Nine Months Ended September 30,

    2023

    2022

    Cash flows from operating activities:
    Consolidated net income

    $

    27,916

     

    $

    27,274

     

    Adjustments to reconcile net income to net cash provided by operating activities:
    Gain on extinguishment of debt

     

    (1,858

    )

     

    -

     

    Loss (gain) on sale of property, plant, and equipment

     

    34

     

     

    (8

    )

    Depreciation and other amortization expense

     

    2,388

     

     

    2,611

     

    Amortization of other intangible assets

     

    2,315

     

     

    1,373

     

    Amortization of deferred financing costs

     

    1,795

     

     

    1,936

     

    Deferred income tax expense (benefit)

     

    694

     

     

    (431

    )

    Stock compensation expense

     

    4,660

     

     

    4,103

     

    Noncash lease income

     

    (48

    )

     

    -

     

    Loss on investments

     

    11,162

     

     

    6,244

     

    Changes in operating assets and liabilities:
    Accounts receivable

     

    (2,112

    )

     

    (5,030

    )

    Inventories

     

    3,036

     

     

    (26,467

    )

    Other current assets

     

    (1,384

    )

     

    1,891

     

    Other assets

     

    (5,110

    )

     

    1,211

     

    Accounts payable

     

    2,865

     

     

    2,074

     

    Accrued liabilities and other

     

    (6,348

    )

     

    (392

    )

    Net cash provided by operating activities

    $

    40,005

     

    $

    16,389

     

     
    Cash flows from investing activities:
    Capital expenditures

    $

    (4,206

    )

    $

    (6,662

    )

    Payments for investments

     

    (200

    )

     

    (1,000

    )

    Restricted cash, MSA escrow deposits

     

    -

     

     

    (10,169

    )

    Proceeds on the sale of property, plant and equipment

     

    3

     

     

    63

     

    Net cash used in investing activities

    $

    (4,403

    )

    $

    (17,768

    )

     
    Cash flows from financing activities:
    Repurchased Convertible Senior Notes

    $

    (41,794

    )

    $

    -

     

    Proceeds from call options

     

    114

     

     

    -

     

    Payment of dividends

     

    (3,354

    )

     

    (3,259

    )

    Exercise of options

     

    419

     

     

    504

     

    Redemption of options

     

    (346

    )

     

    (155

    )

    Redemption of performance restricted stock units

     

    (995

    )

     

    (1,228

    )

    Common stock repurchased

     

    -

     

     

    (27,032

    )

    Net cash used in financing activities

    $

    (45,956

    )

    $

    (31,170

    )

     
    Net decrease in cash

    $

    (10,354

    )

    $

    (32,549

    )

    Effect of foreign currency translation on cash

    $

    22

     

    $

    (324

    )

     
    Cash, beginning of period:
    Unrestricted

    $

    106,403

     

    $

    128,320

     

    Restricted

     

    4,929

     

     

    15,155

     

    Total cash at beginning of period

    $

    111,332

     

    $

    143,475

     

     
    Cash, end of period:
    Unrestricted

    $

    96,071

     

    $

    105,672

     

    Restricted

     

    4,929

     

     

    4,930

     

    Total cash at end of period

    $

    101,000

     

    $

    110,602

     

    Non-GAAP Financial Measures

    To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures, including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Adjusted Gross Profit and Adjusted Operating Income (Loss). We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Adjusted Gross Profit and Adjusted Operating Income (Loss) are used by management to compare our performance to that of prior periods for trend analyses and planning purposes and are presented to our board of directors. We believe that EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Adjusted Gross Profit and Adjusted Operating Income (Loss) are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to business performance.

    We define "EBITDA" as net income before interest expense, gain (loss) on extinguishment of debt, provision for income taxes, depreciation and amortization. We define "Adjusted EBITDA" as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Net Income" as net income excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Diluted EPS" as diluted earnings per share excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Gross Profit: as gross profit excluding other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Operating Income (Loss)" as operating income excluding other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance.

    Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. EBITDA, Adjusted Net Income, Adjusted EBITDA Adjusted Diluted EPS, Adjusted Gross Profit and Adjusted Operating Income (Loss) exclude significant expenses that are required by U.S. GAAP to be recorded in our financial statements and is subject to inherent limitations. In addition, other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure.

    In accordance with SEC rules, we have provided, in the supplemental information attached, a reconciliation of the non-GAAP measures to the next directly comparable GAAP measures.

    Schedule A
     
    Turning Point Brands, Inc.
    Reconciliation of GAAP Net Income to Adjusted EBITDA
    (dollars in thousands)
    (unaudited)

    Three Months Ended

    September 30,

    2023

    2022

    Net income attributable to Turning Point Brands, Inc.

    $

    10,831

     

    $

    11,536

    Add:
    Interest expense, net

     

    3,984

     

     

    4,802

    Gain on extinguishment of debt

     

    (481

    )

     

    -

    Income tax expense

     

    3,767

     

     

    3,797

    Depreciation expense

     

    782

     

     

    861

    Amortization expense

     

    844

     

     

    454

    EBITDA

    $

    19,727

     

    $

    21,450

    Components of Adjusted EBITDA
    Corporate restructuring (a)

     

    190

     

     

    17

    ERP/CRM (b)

     

    138

     

     

    435

    Stock options, restricted stock, and incentives expense (c)

     

    1,824

     

     

    1,442

    Transactional expenses (d)

     

    76

     

     

    -

    FDA PMTA (e)

     

    275

     

     

    1,169

    Non-cash asset impairment (f)

     

    2,173

     

     

    -

    Adjusted EBITDA

    $

    24,403

     

    $

    24,513

     
     
    (a) Represents costs associated with corporate restructuring, including severance.
    (b) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.
    (c) Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units ("PRSUs").
    (d) Represents the fees incurred for transaction expenses.
    (e) Represents costs associated with applications related to FDA premarket tobacco product application ("PMTA").
    (f) Represents impairment of investment assets.
    Schedule B
     
    Turning Point Brands, Inc.
    Reconciliation of GAAP Net Income to Adjusted Net Income and Diluted EPS to Adjusted Diluted EPS
    (dollars in thousands except share data)
    (unaudited) Three Months Ended Three Months Ended
    September 30, 2023 September 30, 2022
    Net Income Diluted EPS Net Income Diluted EPS
    GAAP EPS

    $

    10,831

     

    $

    0.58

     

    $

    11,536

    $

    0.60

    Gain on extinguishment of debt (a)

     

    (357

    )

     

    (0.02

    )

     

    -

     

    -

    Corporate restructuring (b)

     

    141

     

     

    0.01

     

     

    13

     

    0.00

    ERP/CRM (c)

     

    102

     

     

    0.01

     

     

    326

     

    0.02

    Stock options, restricted stock, and incentives expense (d)

     

    1,354

     

     

    0.07

     

     

    1,079

     

    0.05

    Transactional expenses (e)

     

    56

     

     

    0.00

     

     

    -

     

    -

    FDA PMTA (f)

     

    204

     

     

    0.01

     

     

    875

     

    0.04

    Non-cash asset impairment (g)

     

    1,614

     

     

    0.08

     

     

    -

     

    -

    Tax benefit (h)

     

    575

     

     

    0.03

     

     

    469

     

    0.01

    Adjusted

    $

    14,521

     

    $

    0.76

     

    $

    14,297

    $

    0.72

     
     
    Totals may not foot due to rounding
     
    (a) Represents gain on extinguishment of debt tax effected at the quarterly tax rate.
    (b) Represents costs associated with corporate restructuring, including severance, tax effected at the quarterly tax rate.
    (c) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses tax effected at the quarterly tax rate.
    (d) Represents non-cash stock options, restricted stock, incentives expense and Solace PRSUs tax effected at the quarterly tax rate.
    (e) Represents the fees incurred for transaction expenses tax effected at the quarterly tax rate.
    (f) Represents costs associated with applications related to the FDA PMTA tax effected at the quarterly tax rate.
    (g) Represents impairment of investment assets tax effected at the quarterly tax rate.
    (h) Represents adjustment from quarterly tax rate to annual projected tax rate of 23% in 2023 and 2022.
    Schedule C
     
    Turning Point Brands, Inc.
    Reconciliation of GAAP Operating Income (loss) to Adjusted Operating Income (loss)
    (dollars in thousands)
    (unaudited)
    Consolidated Zig-Zag Products Stoker's Products Creative Distribution Solutions

    3rd Quarter

     

    3rd Quarter

     

    3rd Quarter

     

    3rd Quarter

     

    3rd Quarter

     

    3rd Quarter

     

    3rd Quarter

     

    3rd Quarter

    2023

     

    2022

     

    2023

     

    2022

     

    2023

     

    2022

     

    2023

     

    2022

     
    Net sales

    $

    101,722

    $

    107,802

    $

    46,754

    $

    52,061

    $

    36,916

    $

    33,525

    $

    18,052

     

    $

    22,216

     
    Gross profit

    $

    51,622

    $

    52,712

    $

    26,745

    $

    28,035

    $

    20,572

    $

    18,279

    $

    4,305

     

    $

    6,398

     
    Operating income (loss)

    $

    20,237

    $

    19,821

    $

    16,672

    $

    18,740

    $

    15,703

    $

    13,653

    $

    (460

    )

    $

    142

    Adjustments:
    Corporate restructuring

     

    190

     

    17

     

    -

     

    -

     

    -

     

    -

     

    190

     

     

    -

    ERP/CRM

     

    138

     

    435

     

    -

     

    -

     

    -

     

    -

     

    -

     

     

    -

    Transactional expenses

     

    76

     

    -

     

    -

     

    -

     

    -

     

    -

     

    -

     

     

    -

    FDA PMTA

     

    275

     

    1,169

     

    -

     

    -

     

    -

     

    -

     

    -

     

     

    -

    Adjusted operating income (loss)

    $

    20,916

    $

    21,442

    $

    16,672

    $

    18,740

    $

    15,703

    $

    13,653

    $

    (270

    )

    $

    142

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231108282265/en/

    Get the next $TPB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TPB

    DatePrice TargetRatingAnalyst
    8/1/2025Hold
    Needham
    3/3/2025$80.00Buy
    Alliance Global Partners
    11/14/2024$65.00Outperform
    Oppenheimer
    9/19/2024$50.00Buy
    ROTH MKM
    6/6/2023$28.00Buy
    The Benchmark Company
    10/10/2022$28.00 → $22.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $TPB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FRE® Nicotine Pouches Partners with 23XI Driver Riley Herbst to Fuel Performance at NASCAR's Highest Level

    FRE to serve as partner on the No. 35 car, with expanded retail presence through Terrible's locations across Las Vegas FRE® Nicotine Pouches today announced a partnership with 23XI Racing driver Riley Herbst and the No. 35 team, bringing the brand to the NASCAR Cup Series. The partnership pairs FRE with one of the sport's most dynamic young drivers ahead of his hometown race at Las Vegas Motor Speedway on March 15, combining on-track visibility with an expanded retail presence through Terrible's, the Herbst family's well-known chain of convenience locations across the Las Vegas market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/h

    3/12/26 9:00:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Better-for-You Stimulant Formats Gain Scale as Consumer Demand Reshapes Delivery Landscape

    Issued on behalf of Doseology Sciences Inc.VANCOUVER, BC, March 4, 2026 /CNW/ -- USANewsGroup.com News Commentary -- Consumer habits continue to shift, and there's no better example to point at than the rise of pouches. The global oral nicotine pouch market is projected to surge from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR[1]. On top of this, consumer habits are shifting toward tobacco-free formats which are accelerating alongside demand for functional, portable energy delivery systems that eliminate liquid bulk and sugar crashes[2]. This convergence is channeling capital toward consumer goods platforms built around precise dosing, clean ingredients, and mod

    3/4/26 11:51:00 AM ET
    $BTI
    $CELH
    $KDP
    Medicinal Chemicals and Botanical Products
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples

    Turning Point Brands Announces Fourth Quarter and Full Year 2025 Results

    Q4 2025 Modern Oral Net Sales increased 266% to $41.3 million, accounting for 34% of total company net sales, up from 12% in Q4 2024. Q4 2025 adjusted EBITDA increased 14% to $30.0 million. FY 2026 guidance: Modern Oral Gross Revenue of $220-$240 million and Net Revenue of $180-$190 million. Turning Point Brands, Inc. ("TPB" or "the Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, today announced financial results for the fourth quarter and full year ended December 31, 2025. Q4 2025 vs. Q4 2024 Total Consolidated Net Sales increased 29.2% to $121.0 mi

    3/2/26 8:00:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Turning Point Brands Inc.

    SCHEDULE 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    3/27/26 1:36:22 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    SEC Form DEF 14A filed by Turning Point Brands Inc.

    DEF 14A - Turning Point Brands, Inc. (0001290677) (Filer)

    3/25/26 5:05:13 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    SEC Form 10-K filed by Turning Point Brands Inc.

    10-K - Turning Point Brands, Inc. (0001290677) (Filer)

    3/2/26 5:19:12 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Purdy Graham

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    3/26/26 6:00:13 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Sr VP Finance & CAO Wigginton Brian covered exercise/tax liability with 3,906 shares and was granted 6,965 shares, increasing direct ownership by 30% to 13,230 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    3/5/26 7:07:29 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    President and CEO Purdy Graham was granted 64,223 shares and covered exercise/tax liability with 33,976 shares, increasing direct ownership by 13% to 257,345 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    3/5/26 6:05:34 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Turning Point Brands

    Needham initiated coverage of Turning Point Brands with a rating of Hold

    8/1/25 8:13:43 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Alliance Global Partners initiated coverage on Turning Point Brands with a new price target

    Alliance Global Partners initiated coverage of Turning Point Brands with a rating of Buy and set a new price target of $80.00

    3/3/25 8:28:08 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Oppenheimer initiated coverage on Turning Point Brands with a new price target

    Oppenheimer initiated coverage of Turning Point Brands with a rating of Outperform and set a new price target of $65.00

    11/14/24 7:57:59 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Strategy Officer De Plano Lorenzo bought $127,200 worth of shares (4,000 units at $31.80), increasing direct ownership by 13% to 34,896 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/18/24 5:01:10 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Chief Revenue Officer Frein Summer bought $69,970 worth of shares (2,260 units at $30.96), increasing direct ownership by 15% to 17,203 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/14/24 6:50:56 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    De Plano Lorenzo bought $420,753 worth of shares (15,043 units at $27.97), increasing direct ownership by 92% to 31,375 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    3/18/24 9:17:02 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Leadership Updates

    Live Leadership Updates

    View All

    Turning Point Brands Appoints Andrew Flynn as Chief Financial Officer

    Turning Point Brands, Inc. ("TPB" or the "Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today the appointment Andrew Flynn as the Company's new Chief Financial Officer, effective on or before April 1, 2024. Mr. Flynn is replacing Louie Reformina, who will step down to pursue other opportunities. Prior to joining Turning Point Brands, Mr. Flynn served as the CFO of Connected Cannabis Co. where he was responsible for bringing sustained profitable growth, expanding geographically and recapitalizing the company. In this role Mr. Flynn operationalized and

    3/11/24 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel

    GRANT-VALKARIA, Fla., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) ("Kaival Brands," the "Company," or "we"), today announced that it has appointed James W. Dobbins as General Counsel effective December 5, 2023. Barry Hopkins, Executive Chairman of Kaival Brands, said, "James Dobbins has extensive experience advising companies on a breadth of legal matters, and importantly, he also has a deep, relevant understanding of industry business operations, including corporate governance, M&A, international sourcing, and compliance matters. Along with an anticipated reduction in legal expenses, we are thrilled to welcome James to guide and assist our execut

    12/7/23 8:30:00 AM ET
    $KAVL
    $TPB
    Other Consumer Services
    Consumer Discretionary
    Tobacco

    Kaival Brands Appoints New Chief Executive Officer and Chief Financial Officer

    Former Turning Points Brands executive Thomas Metzler brings decades of finance and operational industry experience to Kaival Brands as its new Chief Financial Officer Current President & Chief Operating Officer Eric Mosser promoted to Chief Executive Officer GRANT-VALKARIA, Fla., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) ("Kaival Brands," the "Company" or "we," "our" or similar terms), a company focused on incubating and commercializing innovative products into mature and dominant brands, with a current focus on the distribution of electronic nicotine delivery systems (ENDS), which are intended for adults 21 and over, today announced the appoi

    8/3/23 8:15:00 AM ET
    $KAVL
    $TPB
    Other Consumer Services
    Consumer Discretionary
    Tobacco

    $TPB
    Financials

    Live finance-specific insights

    View All

    Turning Point Brands Announces Fourth Quarter and Full Year 2025 Results

    Q4 2025 Modern Oral Net Sales increased 266% to $41.3 million, accounting for 34% of total company net sales, up from 12% in Q4 2024. Q4 2025 adjusted EBITDA increased 14% to $30.0 million. FY 2026 guidance: Modern Oral Gross Revenue of $220-$240 million and Net Revenue of $180-$190 million. Turning Point Brands, Inc. ("TPB" or "the Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, today announced financial results for the fourth quarter and full year ended December 31, 2025. Q4 2025 vs. Q4 2024 Total Consolidated Net Sales increased 29.2% to $121.0 mi

    3/2/26 8:00:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands Increases Common Stock Dividend

    The Board of Directors of Turning Point Brands, Inc. ("TPB") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients, declared a regular quarterly dividend of $0.08 per common share. This is a 7% increase over the regular quarter dividend declared in November 2025. The dividend is payable on April 10, 2026 to shareholders of record on the close of business on March 20, 2026. About Turning Point Brands, Inc. Turning Point Brands, Inc. (NYSE:TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with ac

    2/25/26 4:37:00 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands to Host Q4 and Fiscal Year 2025 Conference Call

    Turning Point Brands, Inc. (NYSE:TPB) announced the date and time for its conference call to review fourth quarter and fiscal year 2025 results. The conference call will be on Monday, March 2, 2026 at 9 a.m. Eastern. Interested analysts and professional investors can register and participate through one of these call-in numbers: (800) 715-9871 (U.S., toll-free) (646) 307-1963 (International) Event ID: 6640134 Participants should dial in at least 10 minutes in advance and follow the audio prompts after typing in the Event ID. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website at http://www.turningpointbrands.com/in

    2/18/26 8:00:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Turning Point Brands Inc. on Jun 18 Indicate?

    On June 18, 2024, Turning Point Brands Inc. experienced a significant insider purchase when Chief Strategy Officer De Plano Lorenzo bought $127,200 worth of shares. This transaction involved the acquisition of 4,000 units at a price of $31.80 per unit, leading to an increase in his direct ownership by 13% to 34,896 units, as reported in the SEC Form 4. This move by an insider to increase their stake in the company is generally viewed as a positive signal by the market. Examining the recent insider activity at Turning Point Brands Inc., we can identify a few notable trades that occurred around the same time. On May 10, 2024, New insider Catsimatidis John A. Jr claimed ownership of 410,000 sh

    6/18/24 10:08:05 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/14/24 12:37:11 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/8/24 4:32:30 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/8/24 12:58:51 PM ET
    $TPB
    Tobacco
    Consumer Discretionary